ArticleDiabetology & metabolic syndrome2024

The efficacy and safety of GLP-1 receptor agonists in youth with type 2 diabetes: a meta-analysis.

Louise Buonalumi Tacito Yugar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.